Average Co-Inventor Count = 8.98
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (13 from 3,681 patents)
2. Viiv Healthcare UK (no.5) Limited (1 from 42 patents)
3. Viiv Healthcare UK Limited (9 patents)
14 patents:
1. 11505543 - 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
2. 10538555 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
3. 10358463 - Immunomodulators
4. 9879046 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
5. 9850283 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
6. 9598433 - Hepatitis C virus inhibitors
7. 9540323 - [object Object]
8. 9527885 - Hepatitis C virus inhibitors
9. 9499550 - Hepatitis C virus inhibitors
10. 9334279 - Hepatitis C virus inhibitors
11. 9308236 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
12. 8957203 - Hepatitis C virus inhibitors
13. 8835411 - HIV integrase inhibitors
14. 8563505 - Hepatitis C virus inhibitors